YTHDC2 can promote cancer metastasis via enhancing the translating efficiency of hypoxia-inducible factor (HIF)-1α in colon tumor cells, and may become a diagnostic marker and target gene for treating colon cancer patients (32). The gene discussed is HIF1A; the disease is colonic neoplasm.